Abstract
Furazolidone (N-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidinone) in saturated solution in vitro did not affect rat liver monoamine oxidase (MAO). After a single oral dose in rats, however, decreased liver mitochondrial MAO was observed in about 4 hr, and maximal inhibition occurred in 16 to 24 hr. Enzyme activity returned to normal over approximately 21 days. A classical dose-response curve was elicited by oral administration of 2 (no effect) to 100 (complete inhibition) mg/kg, with 50% inhibition being given by 20 mg/kg. Inhibition in brain and liver was cumulative. Combining sonically-lysed mitochondria from control or dosed animals had no effect on the MAO activity of either. A study of nitrofurans and other compounds indicated that the unsubstituted 3-amino-2-oxazolidinone moiety was essential for inhibition in vivo but was inactive in vitro. Of several postulated degradation products of 3-amino-2-oxazolidinone, only 2-hydroxyethyl hydrazine (HEH) fulfilled known structural requirements for MAO inhibition. At 10-6 M in vitro HEH gave 50% inhibition of mitochondrial MAO; 30 min after oral administration of 10 mg/kg, almost complete loss of MAO activity occurred. From the above results, it is proposed that MAO inhibition observed after furazolidone administration may be a result of metabolism in part to HEH.
Footnotes
- Received September 19, 1966.
- Accepted November 28, 1966.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|